Inventor
HUANG LING
US96 patents
⚠️ This page may combine multiple inventors who share the name “HUANG LING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MACROGENICS INC
27 patentsUS7521542B2Apr 21, 2009
Humanized FcγRIIB-specific antibodies and methods of use thereof
MACROGENICS INC105 citations99
US8003774B2Aug 23, 2011
Identification and engineering of antibodies with variant Fc regions and methods of using same
MACROGENICS INC96 citations98
US7960512B2Jun 14, 2011
Identification and engineering of antibodies with variant Fc regions and methods of using same
MACROGENICS INC161 citations98
US7786270B2Aug 31, 2010
Humanized FcγRIIB-specific antibodies and methods of use thereof
MACROGENICS INC55 citations98
US7355008B2Apr 8, 2008
Identification and engineering of antibodies with variant Fc regions and methods of using same
MACROGENICS INC361 citations98
US7351803B2Apr 1, 2008
CD16A binding proteins and use for the treatment of immune disorders
MACROGENICS INC78 citations98
US7112439B2Sep 26, 2006
Dual expression vector system for antibody expression in bacterial and mammalian cells
MACROGENICS INC78 citations97
US9822181B2Nov 21, 2017
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof
MACROGENICS INC62 citations96
US7572456B2Aug 11, 2009
Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof
MACROGENICS INC21 citations93
US10647768B2May 12, 2020
Multi-chain polypeptide-containing tri-specific binding molecules
MACROGENICS INC19 citations92
US10131713B2Nov 20, 2018
HER2/neu-specific antibodies and methods of using same
MACROGENICS INC10 citations92
US9243069B2Jan 26, 2016
HER2/neu-specific antibodies and methods of using the same
MACROGENICS INC13 citations92
US8951517B2Feb 10, 2015
Identification and engineering of antibodies with variant Fc regions and methods of using same
MACROGENICS INC19 citations92
US7838635B2Nov 23, 2010
CD16A binding proteins and use for the treatment of immune disorders
MACROGENICS INC17 citations92
US7618628B2Nov 17, 2009
CD16A binding proteins and use for the treatment of immune disorders
MACROGENICS INC22 citations92
US11028183B2Jun 8, 2021
HER2/neu-specific antibodies and methods of using same
MACROGENICS INC3 citations84
US10150812B2Dec 11, 2018
CD3-binding molecules capable of binding to human and non-human CD3
MACROGENICS INC9 citations84
US10093738B2Oct 9, 2018
Covalent diabodies and uses thereof
MACROGENICS INC7 citations84
US9695236B2Jul 4, 2017
BCR-complex-specific antibodies and methods of using same
MACROGENICS INC11 citations84
US9469692B2Oct 18, 2016
HER2/neu-specific antibodies and methods of using same
MACROGENICS INC8 citations84
US8993730B2Mar 31, 2015
BCR-complex-specific antibodies and methods of using same
MACROGENICS INC10 citations84
US10787521B2Sep 29, 2020
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof
MACROGENICS INC7 citations83
US9896508B2Feb 20, 2018
Antibodies reactive with B7-H3 and uses thereof
MACROGENICS INC8 citations83
US9714295B2Jul 25, 2017
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
MACROGENICS INC6 citations83
US9714296B2Jul 25, 2017
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
MACROGENICS INC7 citations83
US9441049B2Sep 13, 2016
Antibodies reactive with B7-H3 and uses thereof
MACROGENICS INC10 citations83
US7906327B2Mar 15, 2011
Dual expression vector system for antibody expression in bacterial and mammalian cells
MACROGENICS INC9 citations83
JOHNSON LESLIE S
12 patentsUS8802093B2Aug 12, 2014
HER2/neu-specific antibodies and methods of using same
JOHNSON LESLIE S33 citations98
US8133982B2Mar 13, 2012
FcγRIIB specific antibodies and methods of use thereof
JOHNSON LESLIE S54 citations98
US9150656B2Oct 6, 2015
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
JOHNSON LESLIE S47 citations97
US8802091B2Aug 12, 2014
Antibodies reactive with B7-H3 and uses thereof
JOHNSON LESLIE S54 citations96
US9284375B2Mar 15, 2016
Covalent diabodies and uses thereof
JOHNSON LESLIE S31 citations94
US8216579B2Jul 10, 2012
Humanized FcγRIIB-specific antibodies and methods of use thereof
JOHNSON LESLIE S43 citations94
US9296816B2Mar 29, 2016
Covalent diabodies and uses thereof
JOHNSON LESLIE S18 citations93
US9963510B2May 8, 2018
Covalent diabodies and uses thereof
JOHNSON LESLIE S6 citations84
US8795667B2Aug 5, 2014
Compositions for the prevention and treatment of smallpox
JOHNSON LESLIE S13 citations84
US8784808B2Jul 22, 2014
FcγRIIB specific antibodies and methods of use thereof
JOHNSON LESLIE S13 citations84
US9889197B2Feb 13, 2018
Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin
JOHNSON LESLIE S13 citations82
US8785599B2Jul 22, 2014
FcγRIIB—specific antibodies and methods of use thereof
JOHNSON LESLIE S11 citations82
HUANG LING
6 patentsUS9587021B2Mar 7, 2017
CD3-binding molecules capable of binding to human and non-human CD3
HUANG LING45 citations98
USD944799SMar 1, 2022
Stylus
HUANG LING31 citations94
USD936653SNov 23, 2021
Stylus
HUANG LING24 citations94
USD908703SJan 26, 2021
Active stylus
HUANG LING42 citations94
USD909377SFeb 2, 2021
Active stylus
HUANG LING16 citations86
USD909378SFeb 2, 2021
Active stylus
HUANG LING10 citations86
STAVENHAGEN JEFFREY
2 patentsUS9028815B2May 12, 2015
Identification and engineering of antibodies with variant FC regions and methods of using same
STAVENHAGEN JEFFREY24 citations91
US8445645B2May 21, 2013
Identification and engineering of antibodies with variant Fc regions and methods of using same
STAVENHAGEN JEFFREY15 citations91
DEWAN PRASHANT
1 patentUNIV NORTHWESTERN
1 patentJOHNSON LESLIE
1 patentShowing the top 50 of 96 patents by PatentIndex Score.